Yu Shi

7.7k total citations · 1 hit paper
129 papers, 2.8k citations indexed

About

Yu Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Shi has authored 129 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Yu Shi's work include Cancer-related molecular mechanisms research (11 papers), Glioma Diagnosis and Treatment (10 papers) and COVID-19 Clinical Research Studies (9 papers). Yu Shi is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Glioma Diagnosis and Treatment (10 papers) and COVID-19 Clinical Research Studies (9 papers). Yu Shi collaborates with scholars based in China, United States and United Kingdom. Yu Shi's co-authors include Xiu‐Wu Bian, Yi‐Fang Ping, You‐Hong Cui, Cong Chen, Gang Wang, Min Zheng, Zhi Chen, Bo Yang, Lin Zheng and Xiaohong Yao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yu Shi

117 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey

2023 149 citations Mei Zhang, Yu Shi et al. profile →

Peers

Countries citing papers authored by Yu Shi

Since Specialization

Citations

This map shows the geographic impact of Yu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Shi more than expected).

Fields of papers citing papers by Yu Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Shi. The network helps show where Yu Shi may publish in the future.

Co-authorship network of co-authors of Yu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Shi. A scholar is included among the top collaborators of Yu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Shi. Yu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B 2025 ·Hepatology International ·(unknown), Xueyan Yang, Yu‐Xin Tian, Xidong Li, Yingli He, Qiao Yang, (unknown), (unknown), Yue Yu, Lingyun Xu, (unknown), Tao Zhang, Yu Shi, Yu‐Chen Fan	0
2	Multi-regional radiomics for predicting microvascular invasion and lymph node metastasis in intrahepatic cholangiocarcinoma 2025 ·Clinical Radiology ·(unknown), Xianling Qian, Yilei Zhang, Bin Qian, Xu Ma, Cheng‐Ta Yang, Yu Shi	1
3	A Model to Identify Gray Zone Patients With Chronic Hepatitis B Requiring Antiviral Therapy: A Multicenter Retrospective Study 2025 ·The Journal of Infectious Diseases ·Xueyan Yang, Xidong Li, (unknown), Qiao Yang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yue Yu, Lingyun Xu, Yu‐Xin Tian, (unknown), Tao Zhang, Yingli He, Yu Shi, Yu‐Chen Fan	0
4	Identification of Spatial and Symbolic City Image Elements Through Social Media Data: A Case Study of Hangzhou 2024 ·Land ·(unknown), Yu Shi, (unknown), (unknown)	0
5	Correction for: Knockdown of TXNDC9 induces apoptosis and autophagy in glioma and mediates cell differentiation by p53 activation 2024 ·Aging ·Tingting Zheng, Keke Chen, Xue Zhang, Huanhuan Feng, Yu Shi, Li Liu, Jun Zhang, Yun Chen	0
6	A peptide encoded by upstream open reading frame of MYC binds to tropomyosin receptor kinase B and promotes glioblastoma growth in mice 2024 ·Science Translational Medicine ·Fanying Li, Kailin Yang, Xinya Gao, Maolei Zhang, Danling Gu, Xujia Wu, Chenfei Lu, Qiulian Wu, Deobrat Dixit, Ryan C. Gimple, Yongping You, Stephen C. Mack, Yu Shi, Tiebang Kang, Sameer Agnihotri, Michael D. Taylor, Jeremy N. Rich, Nu Zhang, Xiuxing Wang	5
7	Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells 2024 ·Nature Communications ·(unknown), Panpan Liang, Hao Meng, Fangzhen Li, (unknown), (unknown), Wei Wang, Dongxue Li, Cong Chen, Yu Shi, Xingjiang Yu, Yi‐Fang Ping, Chaoshi Niu, Haibo Wu, Aili Zhang, Xiu‐Wu Bian, Wenchao Zhou	21
8	Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia 2024 ·Cytometry Part B Clinical Cytometry ·Xiaohong Chen, (unknown), (unknown), Yu Shi, (unknown), Zhen Guo, Chun Qiao, Huimin Jin, Lìyǐng Zhū, Huayuan Zhu, Jianyong Li, Yujie Wu	1
9	Impact of a high dietary fiber cereal meal intervention on body weight, adipose distribution, and cardiovascular risk among individuals with type 2 diabetes 2023 ·Frontiers in Endocrinology ·Xiaofeng Li, Yu Shi, (unknown), (unknown), (unknown), Xinyi Yan	5
10	Circular RNA encoded MET variant promotes glioblastoma tumorigenesis 2023 ·Nature Communications ·Jian Zhong, Xujia Wu, Yixin Gao, (unknown), Maolei Zhang, Huangkai Zhou, (unknown), Feizhe Xiao, Xuesong Yang, Nunu Huang, (unknown), Xiuxing Wang, Fan Bai, Yu Shi, (unknown)	44
11	Association of high-density lipoprotein cholesterol with all-cause and cause-specific mortality in a Chinese population of 3.3 million adults: a prospective cohort study 2023 ·The Lancet Regional Health - Western Pacific ·Jiapeng Lu, Guiyuan Han, Xiaoying Liu, Bowang Chen, (unknown), Yu Shi, Mei Zhang, Yang Yang, Jianlan Cui, Lijuan Song, Wei Xu, Hao Yang, (unknown), Yan Zhang, Yuan Tian, Li Y, Xi Li	30
12	Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands 2022 ·Nature Communications ·Jian Zhong, Xuesong Yang, (unknown), Kejun He, Xinya Gao, Xujia Wu, Maolei Zhang, Huangkai Zhou, Feizhe Xiao, (unknown), Xiuxing Wang, Yu Shi, Nu Zhang	53
13	High levels of TIMP1 are associated with increased extracellular matrix stiffness in isocitrate dehydrogenase 1-wild type gliomas 2022 ·Laboratory Investigation ·Chunhua Luo, Yu Shi, Yuqi Liu, Qing Liu, Min Mao, Min Luo, Kaidi Yang, Wenying Wang, Cong Chen, Qin Niu, Zexuan Yan, Jingya Miao, Xiaoning Zhang, (unknown), Lei Li, Xiu‐Wu Bian, Yi‐Fang Ping	15
14	Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone 2021 ·Cancers ·Qun Lin, Xiaolin Fang, Gehao Liang, Qing Luo, (unknown), Yu Shi, (unknown), (unknown), Wenqian Yang, Andrew J. Sanders, Chang Gong, Wen G. Jiang	26
15	Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells 2021 ·Laboratory Investigation ·Min Luo, Yuqi Liu, Hua Zhang, Chunhua Luo, Qing Liu, Wenying Wang, Zhicheng He, Cong Chen, Xiaoning Zhang, Min Mao, Kaidi Yang, Chao Wang, Xiaohong Chen, Wenjuan Fu, Qin Niu, Xiu‐Wu Bian, Yu Shi, Yi‐Fang Ping	16
16	Geographical variations in cardiovascular health in China: A nationwide population-based survey of 74,726 adults 2020 ·The Lancet Regional Health - Western Pacific ·Mei Zhang, Yu Shi, Oumin Shi, Zhenping Zhao, (unknown), Chun Li, Zhengjing Huang, Liyun Zhao, Limin Wang, Li Y, Xinhua Li	28
17	Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion 2018 ·Cancer Letters ·Mianfu Cao, Lu Chen, Weiqi Dang, Xianchao Zhang, Xiang Zhang, Yu Shi, Xiaohong Yao, Qian Li, Jiang Zhu, Yong Lin, Sha Liu, Qian Chen, (unknown), Xia Zhang, Xiu‐Wu Bian	24
18	[A survey on knowledge of acupuncture disease spectrum and expectation of acupuncture treatment in Chengdu residents]. 2017 ·PubMed ·Tao Xu, (unknown), Yu Shi, (unknown), Qi Wang, (unknown), (unknown), (unknown), Ling Zhao	1
19	miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma 2015 ·Clinical Cancer Research ·Yu Shi, Cong Chen, Shizhu Yu, Qing Liu, Jun Rao, Huarong Zhang, Hualiang Xiao, Tiwei Fu, Hua Long, Zhicheng He, Kai Zhou, Xiaohong Yao, You‐Hong Cui, Xia Zhang, Yi‐Fang Ping, Xiu‐Wu Bian	49
20	Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma 2014 ·Clinical Cancer Research ·Yu Shi, Cong Chen, (unknown), Qing Liu, Jinling Xu, Huarong Zhang, Xiaohong Yao, Tao Jiang, Zhicheng He, Yong Ren, Wei Cui, Chuan Xu, Ling Liu, You‐Hong Cui, Shizhu Yu, Yi‐Fang Ping, Xiu‐Wu Bian	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Eriksson Breakdown of academic impact, for papers by Veronica Tisato Breakdown of academic impact, for papers by Yang Shen Breakdown of academic impact, for papers by Chian‐Shiu Chien Breakdown of academic impact, for papers by Mario Capasso Breakdown of academic impact, for papers by Michele Caggana Breakdown of academic impact, for papers by Yanwen Chen Breakdown of academic impact, for papers by Jie Xiong